Intra-operative Variation in Size of Brain Tumors After Craniotomy

Status Completed

Clinical Trial Summary

We planned to evaluate the change in tumor dimensions of intraaxial parenchymal tumors after craniotomy by comparing the tumor size on intraoperative ultrasonography (IOUSG) with pre-operative CECT and CEMRI brain.

Clinical Trial Description

Background: No previous study to determine the intraoperative changes in the tumor dimensions had been undertaken previously. Objectives: We planned to evaluate the change in tumor dimensions of intraaxial parenchymal tumors after craniotomy by comparing the tumor size on intraoperative ultrasonography (IOUSG) with pre-operative CECT and CEMRI brain. Study Design: This was a prospective observational study. Participants: Patients aged 15-65 years undergoing surgery at SKIMS for intraaxial parenchymal intracranial tumors were included. Methods: Standard pre-operative CECT and CEMRI brain were done to measure tumor dimensions and compared with IOUSG. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04365647
Study type	Observational
Source	Sheri Kashmir Institute of Medical Sciences
Contact
Status	Completed
Phase
Start date	March 1, 2018
Completion date	March 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06057168` - Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas	Phase 3
Recruiting	`NCT04427384` - Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Completed	`NCT03323450` - Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory	N/A
Completed	`NCT00241670` - Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid	Phase 3
Completed	`NCT02599142` - Comparing Immobilisation Shells in Cranial Radiotherapy	N/A
Not yet recruiting	`NCT01445691` - More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery	Phase 2
Recruiting	`NCT06282562` - FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients	N/A
Recruiting	`NCT06322342` - Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent	Phase 2
Completed	`NCT00001574` - A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Metastatic Brain Tumors
Not yet recruiting	`NCT06185686` - Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients
Withdrawn	`NCT04776980` - Multimodality MRI and Liquid Biopsy in GBM	Early Phase 1
Completed	`NCT03262636` - Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)	Phase 1
Active, not recruiting	`NCT02006407` - A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors	N/A
Recruiting	`NCT03213002` - Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM	Phase 1/Phase 2
Recruiting	`NCT05775458` - Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
Terminated	`NCT04901806` - Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors	Phase 1
Recruiting	`NCT03373487` - Cognitive Rehabilitation in Brain Tumor Patients After Neurosurgery	N/A
Not yet recruiting	`NCT06106997` - Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow	N/A
Recruiting	`NCT05254197` - SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
Recruiting	`NCT05092802` - The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment	Phase 2